Gene Location [1]
Variant Type

MYC Fusion is present in 0.09% of AACR GENIE cases, with diffuse large B-cell lymphoma, not otherwise specified, breast invasive ductal carcinoma, lung adenocarcinoma, endometrial endometrioid adenocarcinoma, and prostate adenocarcinoma having the greatest prevalence [4].

Top Disease Cases with MYC Fusion

Biomarker-Directed Therapies

Significance of MYC Fusion in Diseases

Diffuse Large B-Cell Lymphoma +

Double-Hit Lymphoma +

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified +

Triple-Hit Lymphoma +

Transformed Non-Hodgkin Lymphoma +

High Grade B-Cell Lymphoma With MYC And BCL2 And/Or BCL6 Rearrangements +

High Grade B-Cell Lymphoma, Not Otherwise Specified +

T-Cell/Histiocyte-Rich Large B-Cell Lymphoma +

EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified +

Grade 3b Follicular Lymphoma +

Follicular Lymphoma +

Primary Mediastinal B-Cell Lymphoma +

Burkitt Lymphoma +

Mantle Cell Lymphoma +

B-Cell Non-Hodgkin Lymphoma +

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma +

Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type +

Mediastinal Large B-Cell Lymphoma +

Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation +

Marginal Zone Lymphoma +

ALK-Positive Large B-Cell Lymphoma +

Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma +

HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified +

Non-Hodgkin Lymphoma +

Chronic Lymphocytic Leukemia +

Diffuse Large B-Cell Lymphoma Activated B-Cell Type +

Hodgkin Lymphoma +

Intravascular Large B-Cell Lymphoma +

Multiple Myeloma +

Richter Syndrome +

Acute Lymphoblastic Leukemia +

Burkitt Leukemia +

Mature B-Cell Lymphoma/Leukemia +

Waldenstrom Macroglobulinemia +

Breast Carcinoma +

Malignant Solid Tumor +

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma +

Lymphomatoid Granulomatosis +

Lymphoplasmacytic Lymphoma +

Primary Central Nervous System Lymphoma +

Small Lymphocytic Lymphoma +

Soft Tissue Sarcoma +

Mature B-Cell Non-Hodgkin Lymphoma +

Lymphoma +

Small Cell Lung Carcinoma +

Hematopoietic And Lymphoid Malignancy +

Head And Neck Squamous Cell Carcinoma +

Ovarian Carcinoma +

Acute Myeloid Leukemia +

High Grade Ovarian Serous Adenocarcinoma +

Anal Carcinoma +

Anaplastic Large Cell Lymphoma, ALK-Positive +

Atypical Burkitt/Burkitt-Like Lymphoma +

B-Cell Acute Lymphoblastic Leukemia +

Burkitt-Like Lymphoma With 11q Aberration +

Central Nervous System Lymphoma +

Cervical Carcinoma +

Chronic Myeloid Leukemia +

Composite Lymphoma +

EBV-Positive Mucocutaneous Ulcer +

Extranodal Marginal Zone Lymphoma Of Mucosa-Associated Lymphoid Tissue +

Grade 1 Follicular Lymphoma +

Grade 2 Follicular Lymphoma +

Grade 3 Follicular Lymphoma +

Hairy Cell Leukemia +

Indolent Non-Hodgkin Lymphoma +

Intraocular Lymphoma +

Large B-Cell Lymphoma With IRF4 Rearrangement +

Mature T-Cell And NK-Cell Lymphoma/Leukemia +

Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma +

Nodal Marginal Zone Lymphoma +

Pancreatic Carcinoma +

Penile Carcinoma +

Peripheral T-Cell Lymphoma +

Plasma Cell Leukemia +

Plasmablastic Lymphoma +

Primary Effusion Lymphoma +

Small Intestinal Lymphoma +

Small Lymphocytic Leukemia +

Splenic Marginal Zone Lymphoma +

Vaginal Carcinoma +

Vulvar Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.